DICE Therapeutics, Inc. (DICE) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts DICE Hot Sheet
Join SI Premium – FREE
DICE Therapeutics, Inc. (NASDAQ: DICE) reported Q1 EPS of ($0.54), $0.06 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on DICE Therapeutics, Inc. (DICE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- DA Davidson Reiterates Buy Rating on Wabash National (WNC)
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
